These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17132284)

  • 1. Effect of variability in assay bias and imprecision on external quality assessment bias and imprecision measures.
    Hawkins RC
    Ann Clin Biochem; 2006 Nov; 43(Pt 6):507-9. PubMed ID: 17132284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs.
    Boyd JC; Bruns DE
    Methods Enzymol; 2009; 467():411-433. PubMed ID: 19897102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals.
    Hyltoft Petersen P; Lund F; Fraser CG; Sandberg S; Sölétormos G
    Ann Clin Biochem; 2018 Sep; 55(5):612-615. PubMed ID: 29310466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of analytical quality specifications based on biological within- and between-subject variation.
    Petersen PH; Fraser CG; Jørgensen L; Brandslund I; Stahl M; Gowans E; Libeer JC; Ricós C
    Ann Clin Biochem; 2002 Nov; 39(Pt 6):543-50. PubMed ID: 12564835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical performance specifications for changes in assay bias (Δbias) for data with logarithmic distributions as assessed by effects on reference change values.
    Petersen PH; Lund F; Fraser CG; Sölétormos G
    Ann Clin Biochem; 2016 Nov; 53(6):686-691. PubMed ID: 27147623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprecision remains to be improved in the measurement of serum cystatin C with heterogeneous systems.
    Zeng J; Zhang L; Zhang J; Zhou W; Zhang T; Wang J; Zhao H; Zhang C
    Clin Chem Lab Med; 2023 Jul; 61(8):1455-1462. PubMed ID: 36866730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An accurate substitution method for analyzing censored data.
    Ganser GH; Hewett P
    J Occup Environ Hyg; 2010 Apr; 7(4):233-44. PubMed ID: 20169489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for treating femoral shaft fractures in children and adolescents.
    Madhuri V; Dutt V; Gahukamble AD; Tharyan P
    Evid Based Child Health; 2014 Dec; 9(4):753-826. PubMed ID: 25504970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of imprecision in collaborative immunoassay quality-assessment programmes.
    Compton P; Cole B; Stuart M; Egan G
    Ann Clin Biochem; 1984 Nov; 21 ( Pt 6)():498-503. PubMed ID: 6517490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix effects and accuracy assessment. Identifying matrix-sensitive methods from real-time proficiency testing data.
    Lawson NS; Williams TL; Long T
    Arch Pathol Lab Med; 1993 Apr; 117(4):401-11. PubMed ID: 8466404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of imprecision in immunoassay quality assessment programmes.
    Sadler WA; Smith MH
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():98-106. PubMed ID: 3827192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated quantitation of fetomaternal hemorrhage by flow cytometry for HbF-containing fetal red blood cells using probability state modeling.
    Wong L; Hunsberger BC; Bruce Bagwell C; Davis BH
    Int J Lab Hematol; 2013 Oct; 35(5):548-54. PubMed ID: 23521723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring and drugs of abuse testing on the cobas 6000 analyzer series: analytical performance under routine-like conditions.
    Brandhorst G; Luthe H; Domke I; Knoke C; Rhode KH; Sauter H; Oellerich M
    Clin Chem Lab Med; 2009; 47(7):854-9. PubMed ID: 19496737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of several methods for analyzing censored data.
    Hewett P; Ganser GH
    Ann Occup Hyg; 2007 Oct; 51(7):611-32. PubMed ID: 17940277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?
    Petersen PH; Sandberg S; Fraser CG
    Clin Chem Lab Med; 2011 Apr; 49(4):637-40. PubMed ID: 21345044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of optimal replicate number for validation of imprecision using fluorescence cell-based assays: proposed practical method.
    Davis BH; McLaren CE; Carcio AJ; Wong L; Hedley BD; Keeney M; Curtis A; Culp NB
    Cytometry B Clin Cytom; 2013; 84(5):329-37. PubMed ID: 24022856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of optimal replicate number for validation of imprecision using fluorescence cell based assays: Proposed practical method.
    Davis BH; McLaren CE; Carcio AJ; Wong L; Hedley BD; Keeney M; Curtis A; Culp NB
    Cytometry B Clin Cytom; 2013 Jul; ():. PubMed ID: 23873644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
    Kjellsson MC; Jönsson S; Karlsson MO
    AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.